Á lódáil...
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. First-line treatment is based on the use of high doses of corticosteroids. Unfortunately, second-line treatment for both acute and chronic graft-versus-host disease, remai...
Na minha lista:
| Foilsithe in: | Bone Marrow Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Nature Publishing Group UK
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7051903/ https://ncbi.nlm.nih.gov/pubmed/31700138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-019-0731-x |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|